Nutra Pharma Corp (NPHC)

[fly_fisherman]

READ: Chronic pain patients: 'War' on opioid epidemic could kill us


Legitimate concerns by folks with chronic pain!!!

February 3, 2018

https://www.clarionledger.com/story/news/2018/02/02/chronic-pain-patients-war-opioid-epidemic-could-kill-us/1081785001/


FROM THE ARTICLE:

Many chronic pain patients, who don't suffer from cancer or other fatal diseases, worry they will become the casualties in the battle against the opioid epidemic.

"It's like a war on chronic pain patients," said Jaqueline Schneider, a 56-year-old Pittsburgh woman who suffers from two rare spine diseases. "Nobody mentions legitimate pain patients. It's like we have the plague."


Dennis Ewing Sr., a 61-year-old disabled printer in San Antonio, takes the equivalent of 135 mg of morphine a day for his intense spinal pain.

The U.S. Centers for Disease Control and Prevention has recommended health care providers prescribe no more than a 90 mg morphine equivalent and justify it whenever they go beyond that amount.

He knows he is physically dependent on opioids and would encounter withdrawal if he went off the drug, "but I'm not an addict," he said. "I've been fighting this pain since the 1990s."




COMMENTS:

NUTRA PHARMA HAS A SOLUTION BETTER THAN MORPHINE!!!

Nyloxin works perfectly in the transition off the Opioids!!!

Nyloxin is all-natural, anti-inflammatory, analgesic pain relief that is non-toxic, non-narcotic, non-addictive, non-steroidal and does not contain aspirin or acetaminophen !!!

“Nyloxin product is amazing. It’s non-addictive, no opiate, non-narcotic In the last model, it outperformed morphine. It lasted 4-6 hours longer than morphine without any of the side effects. Additionally, since the dose of Nyloxin is so small compared to the dose of morphine required, the Nyloxin was considered to be approximately 600 times more potent than the morphine on a molecular basis,” explained Rik Deitsch, CEO of Nutra Pharma Corp..


We have also stated that there are no contraindications in utilizing the Nyloxin with opiate drugs. In fact, since their mechanisms of action are so vastly different, we have seen a synergistic benefit. The recommendation is to continue the use of the opiate while introducing Nyloxin to the patient protocol. After a few weeks, most people can reduce their opiate use and many people have even eliminated their use of opiates over time in favor of the Nyloxin.

FOLKS THIS REPRESENTS A PARADIGM CHANGE IN TREATING PAIN and TRANSITIONING OFF OPIOIDS!!!

!!!!!!!!DISRUPTIVE SOLUTIONS!!!!!!!

$NPHC$ IS RIGHT SMACK DAB IN THE SWEETSPOT!!!

$NPHC$ Short Term Target: .02-.05!!!